ReposiTrak (NYSE:TRAK) CEO Randall Fields Sells 3,000 Shares

ReposiTrak Inc. (NYSE:TRAKGet Free Report) CEO Randall Fields sold 3,000 shares of the firm’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $8.82, for a total transaction of $26,460.00. Following the sale, the chief executive officer owned 107,500 shares of the company’s stock, valued at approximately $948,150. This represents a 2.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

ReposiTrak Price Performance

ReposiTrak stock traded down $0.26 during trading hours on Friday, hitting $8.73. The company had a trading volume of 116,394 shares, compared to its average volume of 75,596. The firm has a market cap of $158.91 million, a PE ratio of 23.59 and a beta of 0.45. ReposiTrak Inc. has a one year low of $8.69 and a one year high of $23.72. The firm has a 50-day moving average of $11.38 and a 200 day moving average of $14.02.

ReposiTrak (NYSE:TRAKGet Free Report) last issued its quarterly earnings data on Tuesday, February 17th. The company reported $0.09 earnings per share (EPS) for the quarter. ReposiTrak had a return on equity of 14.52% and a net margin of 30.62%.The company had revenue of $5.86 million during the quarter.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on TRAK shares. Wall Street Zen cut ReposiTrak from a “buy” rating to a “hold” rating in a research report on Saturday, January 17th. Weiss Ratings restated a “hold (c+)” rating on shares of ReposiTrak in a research note on Monday, December 29th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has an average rating of “Hold”.

Check Out Our Latest Stock Analysis on ReposiTrak

Hedge Funds Weigh In On ReposiTrak

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. XTX Topco Ltd bought a new stake in shares of ReposiTrak during the 4th quarter valued at $214,000. Occudo Quantitative Strategies LP acquired a new position in ReposiTrak in the fourth quarter valued at about $147,000. Price T Rowe Associates Inc. MD lifted its position in ReposiTrak by 23.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 28,094 shares of the company’s stock worth $348,000 after purchasing an additional 5,400 shares during the period. Rice Hall James & Associates LLC grew its stake in ReposiTrak by 6.4% during the fourth quarter. Rice Hall James & Associates LLC now owns 793,858 shares of the company’s stock worth $9,820,000 after buying an additional 47,914 shares in the last quarter. Finally, Squarepoint Ops LLC increased its holdings in ReposiTrak by 39.5% in the 4th quarter. Squarepoint Ops LLC now owns 99,830 shares of the company’s stock valued at $1,235,000 after buying an additional 28,282 shares during the period. 27.35% of the stock is owned by institutional investors and hedge funds.

About ReposiTrak

(Get Free Report)

ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company’s platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.

At the core of ReposiTrak’s offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.

Recommended Stories

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

Receive News & Ratings for ReposiTrak Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReposiTrak and related companies with MarketBeat.com's FREE daily email newsletter.